Annual Total Assets
$1.82 B
-$1.34 B-42.42%
31 December 2023
Summary:
Emergent BioSolutions annual total assets is currently $1.82 billion, with the most recent change of -$1.34 billion (-42.42%) on 31 December 2023. During the last 3 years, it has fallen by -$1.06 billion (-36.76%). EBS annual total assets is now -42.42% below its all-time high of $3.17 billion, reached on 31 December 2022.EBS Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$1.48 B
-$35.70 M-2.36%
30 September 2024
Summary:
Emergent BioSolutions quarterly total assets is currently $1.48 billion, with the most recent change of -$35.70 million (-2.36%) on 30 September 2024. Over the past year, it has dropped by -$415.30 million (-21.94%). EBS quarterly total assets is now -53.33% below its all-time high of $3.17 billion, reached on 31 December 2022.EBS Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.4% | -21.9% |
| 3 y3 years | -36.8% | -48.5% |
| 5 y5 years | -18.2% | -36.7% |
EBS Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -42.4% | at low | -53.3% | at low |
| 5 y | 5 years | -42.4% | at low | -53.3% | at low |
| alltime | all time | -42.4% | +7900.0% | -53.3% | +2040.0% |
Emergent BioSolutions Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.48 B(-2.4%) |
| June 2024 | - | $1.51 B(-16.1%) |
| Mar 2024 | - | $1.80 B(-1.1%) |
| Dec 2023 | $1.82 B(-42.4%) | $1.82 B(-3.7%) |
| Sept 2023 | - | $1.89 B(-13.1%) |
| June 2023 | - | $2.18 B(-26.1%) |
| Mar 2023 | - | $2.95 B(-6.8%) |
| Dec 2022 | $3.17 B(+7.1%) | $3.17 B(+8.9%) |
| Sept 2022 | - | $2.91 B(+6.3%) |
| June 2022 | - | $2.74 B(-1.6%) |
| Mar 2022 | - | $2.78 B(-6.0%) |
| Dec 2021 | $2.96 B(+2.6%) | $2.96 B(+3.1%) |
| Sept 2021 | - | $2.87 B(-1.6%) |
| June 2021 | - | $2.92 B(+0.5%) |
| Mar 2021 | - | $2.90 B(+0.6%) |
| Dec 2020 | $2.88 B(+23.9%) | $2.88 B(+10.2%) |
| Sept 2020 | - | $2.62 B(+6.1%) |
| June 2020 | - | $2.47 B(+8.2%) |
| Mar 2020 | - | $2.28 B(-2.1%) |
| Dec 2019 | $2.33 B(+4.4%) | $2.33 B(-0.3%) |
| Sept 2019 | - | $2.33 B(+0.5%) |
| June 2019 | - | $2.32 B(+7.8%) |
| Mar 2019 | - | $2.15 B(-3.4%) |
| Dec 2018 | $2.23 B(+108.3%) | $2.23 B(+90.0%) |
| Sept 2018 | - | $1.17 B(+3.0%) |
| June 2018 | - | $1.14 B(+6.6%) |
| Mar 2018 | - | $1.07 B(-0.2%) |
| Dec 2017 | $1.07 B(+10.3%) | $1.07 B(+4.5%) |
| Sept 2017 | - | $1.02 B(+5.5%) |
| June 2017 | - | $970.48 M(+2.0%) |
| Mar 2017 | - | $951.64 M(-1.9%) |
| Dec 2016 | $970.11 M(-6.5%) | $970.11 M(+4.1%) |
| Sept 2016 | - | $932.03 M(-11.8%) |
| June 2016 | - | $1.06 B(+2.0%) |
| Mar 2016 | - | $1.04 B(-0.2%) |
| Dec 2015 | $1.04 B | $1.04 B(+6.2%) |
| Sept 2015 | - | $976.55 M(+3.5%) |
| June 2015 | - | $943.32 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $917.85 M(-2.2%) |
| Dec 2014 | $938.69 M(+49.8%) | $938.69 M(+8.0%) |
| Sept 2014 | - | $869.29 M(+3.8%) |
| June 2014 | - | $837.25 M(+1.7%) |
| Mar 2014 | - | $823.25 M(+31.4%) |
| Dec 2013 | $626.63 M(+11.1%) | $626.63 M(+5.2%) |
| Sept 2013 | - | $595.46 M(+7.2%) |
| June 2013 | - | $555.61 M(+3.2%) |
| Mar 2013 | - | $538.38 M(-4.6%) |
| Dec 2012 | $564.23 M(+3.2%) | $564.23 M(+4.5%) |
| Sept 2012 | - | $540.02 M(+2.4%) |
| June 2012 | - | $527.14 M(+2.4%) |
| Mar 2012 | - | $514.69 M(-5.9%) |
| Dec 2011 | $546.86 M(+9.3%) | $546.86 M(+6.6%) |
| Sept 2011 | - | $512.96 M(+3.8%) |
| June 2011 | - | $493.98 M(+4.8%) |
| Mar 2011 | - | $471.28 M(-5.8%) |
| Dec 2010 | $500.32 M(+45.2%) | $500.32 M(+36.6%) |
| Sept 2010 | - | $366.24 M(+5.9%) |
| June 2010 | - | $345.75 M(+0.9%) |
| Mar 2010 | - | $342.79 M(-0.6%) |
| Dec 2009 | $344.69 M(+18.5%) | $344.69 M(+8.8%) |
| Sept 2009 | - | $316.80 M(-2.9%) |
| June 2009 | - | $326.38 M(+7.4%) |
| Mar 2009 | - | $303.78 M(+4.5%) |
| Dec 2008 | $290.79 M(+6.3%) | $290.79 M(+1.2%) |
| Sept 2008 | - | $287.40 M(+3.4%) |
| June 2008 | - | $277.92 M(+1.6%) |
| Mar 2008 | - | $273.64 M(+0.0%) |
| Dec 2007 | $273.51 M(+14.8%) | $273.51 M(+20.6%) |
| Sept 2007 | - | $226.75 M(+9.5%) |
| June 2007 | - | $207.00 M(+1.5%) |
| Mar 2007 | - | $203.89 M(-14.4%) |
| Dec 2006 | $238.25 M(+137.5%) | $238.25 M(+82.1%) |
| Sept 2006 | - | $130.83 M(+30.4%) |
| Dec 2005 | $100.33 M(+45.3%) | $100.33 M(+45.3%) |
| Dec 2004 | $69.06 M(+203.0%) | $69.06 M |
| Dec 2002 | $22.79 M(-10.4%) | - |
| Dec 2001 | $25.42 M | - |
FAQ
- What is Emergent BioSolutions annual total assets?
- What is the all time high annual total assets for Emergent BioSolutions?
- What is Emergent BioSolutions annual total assets year-on-year change?
- What is Emergent BioSolutions quarterly total assets?
- What is the all time high quarterly total assets for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly total assets year-on-year change?
What is Emergent BioSolutions annual total assets?
The current annual total assets of EBS is $1.82 B
What is the all time high annual total assets for Emergent BioSolutions?
Emergent BioSolutions all-time high annual total assets is $3.17 B
What is Emergent BioSolutions annual total assets year-on-year change?
Over the past year, EBS annual total assets has changed by -$1.34 B (-42.42%)
What is Emergent BioSolutions quarterly total assets?
The current quarterly total assets of EBS is $1.48 B
What is the all time high quarterly total assets for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly total assets is $3.17 B
What is Emergent BioSolutions quarterly total assets year-on-year change?
Over the past year, EBS quarterly total assets has changed by -$415.30 M (-21.94%)